Skip to main content

Global Tamoxifen Market to Reach Worth USD 683.7 Mn by 2022: Emerging Countries to Witness Higher Demand

According to the latest report published by Credence Research, Inc. “Tamoxifen Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the tamoxifen market was valued at USD 675.7 Mn in 2015, and is expected to reach USD 683.6 Mn by 2022, expanding at a CAGR of 0.07% from 2016 to 2022.
Browse the full report Tamoxifen: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/tamoxifen-market
Market Insights
Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.
This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.
Proven long-term efficiency of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients that cannot opt for surgery, and late-stage and recurrent breast cancer, and widespread use of tamoxifen as adjuvant therapy are the prime factors driving the demand for tamoxifen. Growth of tamoxifen-resistant cancer and growing awareness about the drug inducing endometrial cancer may restrain the market growth. Growing application of tamoxifen in treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.
The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition.
ToC
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition................
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
 

Comments

Popular posts from this blog

Rigid Plastic Packaging Market – Global Market Size, Share, Trend, Market Growth, Analysis And Industry Forecasts to 2026

The latest market report published by Credence Research, Inc. “Rigid Plastic Packaging Market By Resin Type (Polyethylene, Polyethylene Terephthalate, Polypropylene, Polystyrene, Polyvinyl Chloride, Expanded Polystyrene, Others), By End-use industry (Beverages, Food, Healthcare, Personal Care, Industrial, Others), By Type (Bottles & Jars, Trays, Tubs Cups & Pots, Rigid Bulk Products and Others) and By Region (North America, Europe, Asia Pacific, Latin America, & Middle East & Africa) – Growth, Future Prospects and Competitive Analysis, 2017 – 2025,” the global rigid plastic packaging market was valued at US$ 195.56 Bn in 2016, expanding at a CAGR of 5.7% from 2017 to 2025. Market Insights Rigid plastic packaging possesses features such as lightweight, flexible, and durable, which makes it suitable solution for packaging of products used in different industries such as beverages, food, healthcare, personal care and so on. Rigid plastic packaging products includes bottle…

Global Wound Closure Surgical Products Market is Expected to Reach US$ 26.3 Bn by 2025: Credence Research

The latest market report published by Credence Research, Inc. “Wound Closure Surgical Products Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” the wound closure surgical products market was valued at US$ 14.5 Bn in 2016 and is expected to reach US$ 26.3 Bn 2025, expanding at a CAGR of 6.8% from 2017 to 2025. Browse the full report Wound Closure Surgical Products Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025 report at http://www.credenceresearch.com/report/wound-closure-surgical-products-market Market Insights: There is an increase in demand for cost efficient surgical procedures that assist in sealing of tissues and providing complete closure of wounds with total recovery. Wound closure surgical products are available in various forms viz., hemostats, tissue sealants, adhesives, ligating clips, wound closure strips, mechanical stapling device and sutures. Wound closures surgical products are predominantly used for surgical closures which…

Global Automated External Defibrillators Market Projected To Grow At A Significant Rate Of 7.2% From 2017–2025: Credence Research

According to the latest report published by Credence Research, Inc. “Automated External Defibrillators MarketGrowth, Future Prospects and Competitive Analysis, 2017-2025,” the global automated external defibrillators market is projected to grow at a significant rate of 7.2% from 2017-2025. Browse the full report Automated External Defibrillators Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/automated-external-defibrillators-market Market Insights                                                   Automated external defibrillators (AEDs) are portable and lightweight devices that deliver electrical shock to the heart in case of sudden cardiac arrest (SCA). SCA is a condition wherein the heart stops beating unexpectedly, leading to death if not treated at the earliest. According to America Heart Association (AHA), SCA is a leading cause of death globally, accounting for more than 350,000 medical emergencies every year in the …